Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 17

1.

Single Nucleotide Polymorphisms in Cellular Drug Transporters Are Associated with Intolerance to Antiretroviral Therapy in Brazilian HIV-1 Positive Individuals.

Arruda MB, Campagnari F, de Almeida TB, Couto-Fernandez JC, Tanuri A, Cardoso CC.

PLoS One. 2016 Sep 20;11(9):e0163170. doi: 10.1371/journal.pone.0163170. eCollection 2016.

2.

Prevalence of and Risk Factors for Lipoatrophy in Patients with HIV Infection in Nigeria.

Iwuala SO, Lesi OA, Fasanmade OA, Sabir AA, Olamoyegun MA, Okany CC.

AIDS Res Treat. 2015;2015:402638. doi: 10.1155/2015/402638. Epub 2015 Mar 2.

3.

Pharmacogenomics of antimicrobial agents.

Aung AK, Haas DW, Hulgan T, Phillips EJ.

Pharmacogenomics. 2014;15(15):1903-30. doi: 10.2217/pgs.14.147. Review.

4.

Genetic variation in iron metabolism is associated with neuropathic pain and pain severity in HIV-infected patients on antiretroviral therapy.

Kallianpur AR, Jia P, Ellis RJ, Zhao Z, Bloss C, Wen W, Marra CM, Hulgan T, Simpson DM, Morgello S, McArthur JC, Clifford DB, Collier AC, Gelman BB, McCutchan JA, Franklin D, Samuels DC, Rosario D, Holzinger E, Murdock DG, Letendre S, Grant I; CHARTER Study Group.

PLoS One. 2014 Aug 21;9(8):e103123. doi: 10.1371/journal.pone.0103123. eCollection 2014.

6.

Mitochondrial DNA variation and changes in adiponectin and endothelial function in HIV-infected adults after antiretroviral therapy initiation.

Hulgan T, Stein JH, Cotter BR, Murdock DG, Ritchie MD, Dube MP, Gerschenson M, Haas DW, Torriani FJ; Aids Clinical Trials Group A5152s And Dacs 252 Study Teams.

AIDS Res Hum Retroviruses. 2013 Oct;29(10):1293-9. doi: 10.1089/aid.2013.0079. Epub 2013 Aug 14.

7.

Mitochondrial genomics and antiretroviral therapy-associated metabolic complications in HIV-infected Black South Africans: a pilot study.

Sinxadi PZ, Dave JA, Samuels DC, Heckmann JM, Maartens G, Levitt NS, Wester CW, Haas DW, Hulgan T.

AIDS Res Hum Retroviruses. 2013 Jul;29(7):1031-9. doi: 10.1089/AID.2012.0373. Epub 2013 Mar 15.

8.

Individualization of antiretroviral therapy.

Pavlos R, Phillips EJ.

Pharmgenomics Pers Med. 2012;5:1-17. doi: 10.2147/PGPM.S15303. Epub 2011 Dec 29.

9.

Mitochondrial DNA variation and HIV-associated sensory neuropathy in CHARTER.

Holzinger ER, Hulgan T, Ellis RJ, Samuels DC, Ritchie MD, Haas DW, Kallianpur AR, Bloss CS, Clifford DB, Collier AC, Gelman BB, Marra CM, McArthur JC, McCutchan JA, Morgello S, Simpson DM, Franklin DR, Rosario D, Selph D, Letendre S, Grant I; CHARTER Group.

J Neurovirol. 2012 Dec;18(6):511-20. doi: 10.1007/s13365-012-0133-y. Epub 2012 Oct 17.

10.

Nutrigenomics and personalized diets: What will they mean for food?

German JB, Zivkovic AM, Dallas DC, Smilowitz JT.

Annu Rev Food Sci Technol. 2011;2:97-123. doi: 10.1146/annurev.food.102308.124147. Review.

11.

New and emerging agents in the management of lipodystrophy in HIV-infected patients.

Bonnet E.

HIV AIDS (Auckl). 2010;2:167-78. doi: 10.2147/HIV.S13429. Epub 2010 Sep 17.

12.

No longitudinal mitochondrial DNA sequence changes in HIV-infected individuals with and without lipoatrophy.

Ortiz M, Poloni ES, Furrer H, Kovari H, Martinez R, Arnedo M, Elzi L, Bernasconi E, Vernazza P, Hirschel B, Cavassini M, Ledergerber B, G√ľnthard HF, Telenti A, Tarr PE; Swiss HIV Cohort Study.

J Infect Dis. 2011 Mar 1;203(5):620-4. doi: 10.1093/infdis/jiq106. Epub 2011 Jan 12.

13.

European mitochondrial DNA haplogroups and metabolic changes during antiretroviral therapy in AIDS Clinical Trials Group Study A5142.

Hulgan T, Haubrich R, Riddler SA, Tebas P, Ritchie MD, McComsey GA, Haas DW, Canter JA.

AIDS. 2011 Jan 2;25(1):37-47. doi: 10.1097/QAD.0b013e32833f9d02.

14.

Lack of association between stavudine exposure and lipoatrophy, dysglycaemia, hyperlactataemia and hypertriglyceridaemia: a prospective cross sectional study.

Sinxadi PZ, van der Walt JS, McIlleron HM, Badri M, Smith PJ, Dave JA, Levitt NS, Maartens G.

AIDS Res Ther. 2010 Jul 14;7:23. doi: 10.1186/1742-6405-7-23.

15.

Mitochondrial haplogroups are associated with risk of neuroretinal disorder in HIV-positive patients.

Hendrickson SL, Jabs DA, Van Natta M, Lewis RA, Wallace DC, O'Brien SJ.

J Acquir Immune Defic Syndr. 2010 Apr 1;53(4):451-5. doi: 10.1097/QAI.0b013e3181cb8319.

16.

Pharmacogenetics of nucleoside reverse-transcriptase inhibitor-associated peripheral neuropathy.

Kallianpur AR, Hulgan T.

Pharmacogenomics. 2009 Apr;10(4):623-37. doi: 10.2217/pgs.09.14.

17.

Mitochondrial DNA haplogroups influence lipoatrophy after highly active antiretroviral therapy.

Hendrickson SL, Kingsley LA, Ruiz-Pesini E, Poole JC, Jacobson LP, Palella FJ, Bream JH, Wallace DC, O'Brien SJ.

J Acquir Immune Defic Syndr. 2009 Jun 1;51(2):111-6. doi: 10.1097/QAI.0b013e3181a324d6.

Supplemental Content

Support Center